Medical application of ursolic acid-NF (Nuclear Factor)-kappaB inhibitor

A technology of ursolic acid and inhibitor, which is applied in the field of medical use of ursolic acid-NF-kappaB inhibitor, can solve the problems of inability to clinically apply, no drug has been found, etc., and achieves small molecular size, reduced rejection, and structural stable effect

Inactive Publication Date: 2011-10-05
TONGJI HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI TECH
View PDF1 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, tens of thousands of research reports around the world have verified the importance of this molecular signal and the therapeutic effect that can be achieved after blocking it, bu

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medical application of ursolic acid-NF (Nuclear Factor)-kappaB inhibitor
  • Medical application of ursolic acid-NF (Nuclear Factor)-kappaB inhibitor
  • Medical application of ursolic acid-NF (Nuclear Factor)-kappaB inhibitor

Examples

Experimental program
Comparison scheme
Effect test
No Example Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides medical application of an ursolic acid-NF (Nuclear Factor)-kappaB inhibitor and relates to application of an NF-kappaB inhibitor as an immunomodifier in the field of medicine and scientific research. As the immunomodifier, the ursolic acid-NF-kappaB inhibitor is used for preparing immunity inhibitor medicines and used in aspects of treating rejection after reducing transplantation and inducing and maintaining transplantation tolerance. As the immunomodifier, the ursolic acid-NF-kappaB inhibitor is used as antiinflammatory drugs and used for treating multiple chronic inflammatory diseases. As the immunomodifier, the ursolic acid-NF-kappaB inhibitor is used for preparing ischemia reperfusion injury protective agents and used for treating ischemia reperfusion injury diseases. As the immunomodifier, the ursolic acid-NF-kappaB inhibitor is used for preparing drugs for preventing and treating endotoxemia and septicopyemia and used for preventing and treating the endotoxemia and the septicopyemia.

Description

technical field [0001] The present invention relates to the application of an NF-kappaB inhibitor as an immunomodulator in the field of medicine and scientific research, especially in anti-transplant rejection, anti-autoimmune disease, anti-ischemia-reperfusion injury, anti-chronic inflammatory response, and anti-endotoxemia and other uses. Background technique [0002] Before the present invention was proposed, medical experts in the field knew very well that the inhibitory regulation of the immune system of the body is the key to the treatment of various diseases, such as the treatment of rejection after organ transplantation, autoimmune diseases, chronic inflammatory diseases, ischemia, etc. reperfusion injury, etc. The regulation of the immune system can start from many aspects, and the innate immune response, as a hot spot in recent research, is an excellent direction to achieve immunosuppression. [0003] The body's immune response is divided into innate immunity and...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07J63/00A61K31/56A61P37/06A61P29/00A61P37/02A61P9/10A61P39/02A61P35/00A61P3/10
Inventor 周平刘勇薛承彪
Owner TONGJI HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products